TY - JOUR T1 - Depigmentation Outcomes in Pigmented Oral Lichen Planus Managed With Mycophenolate Mofetil. AU - Biswas,Tania, AU - Bajoria,Atul Anand, AU - Nahar,Noureen, AU - Sinha,Pallawi, AU - Sharan,Jitendra, AU - Basynat,Smriti K C, Y1 - 2026/05/22/ PY - 2025/12/15/received PY - 2026/4/30/revised PY - 2026/5/14/accepted PY - 2026/6/8/medline PY - 2026/6/8/pubmed PY - 2026/6/8/entrez PY - 2026/5/22/pmc-release KW - hyperpigmentation KW - immunosuppressants KW - mycophenolate mofetil KW - oral lichen planus KW - refractory lesions SP - e72765 EP - e72765 JF - Clinical case reports JO - Clin Case Rep VL - 14 IS - 6 N2 - Pigmented oral lichen planus (OLP) is a chronic, immune-mediated mucosal disorder associated with dark black or brown discoloration secondary to the excess melanin deposition. This medical condition is often accompanied by the typical white (reticular) or red (erosive) OLP features and is refractory to conventional therapy. We report a case of OLP which was successfully managed with oral mycophenolate mofetil (MMF), resulting in significant symptomatic relief and reduction of hyperpigmentation. MMF offers a safe and effective systemic option for persistent pigmented OLP. SN - 2050-0904 UR - https://www.unboundmedicine.com/prime/citation/42256961/Depigmentation_Outcomes_in_Pigmented_Oral_Lichen_Planus_Managed_With_Mycophenolate_Mofetil. DB - PRIME DP - Unbound Medicine ER -